Medical News

RSS

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Teleflex Incorporated, a global provider of medical technology products, announced a global distribution agreement with Perouse Medical under which Teleflex will distribute the Perouse line of POLYSITE® intravenous implantable infusion ports.

25 Mar 2011

Swallowed button battery can generate electrical current and cause serious tissue damage

To mark National Poison Prevention week, Trauma specialists at The Montreal Children's Hospital (MCH) of the McGill University Health Centre are urging parents to seek immediate medical attention if their child has swallowed a button battery. Parents should not assume the tiny battery will harmlessly pass through their child's system.

25 Mar 2011

Tengion 2010 adjusted net loss decreases to $25.8 million

Tengion, Inc. today provided a business update and reported its financial results for the year ended December 31, 2010.

25 Mar 2011

US District Court rules against Watson in generic Fentora patent suit

Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.

25 Mar 2011

Emory plays key role in bringing advanced proton cancer therapy to Georgia

Emory Healthcare is a key player in plans to bring the world's most advanced radiation treatment for cancer patients to Georgia. In furtherance of that role, Emory Healthcare has signed a letter of intent with Advanced Particle Therapy, LLC, of Minden, Nevada, opening the door to a final exploratory phase for development of The Georgia Proton Treatment Center - Georgia's first proton therapy facility.

25 Mar 2011

Moving quickly across slippery surfaces reduces chances of falling

Biomechanics researchers Timothy Higham of Clemson University and Andrew Clark of the College of Charleston conclude that moving quickly in a forward, firm-footed stance across a slippery surface is less likely to lead to a fall than if you move slowly. Approaching a slippery surface slowly hinders the necessary task of shifting the center of mass forward once foot contact is made.

25 Mar 2011

Countries ban imports of Japanese food as radiation leak continues

Countries worldwide on Thursday banned or limited food imports from Japan, as radioactive steam continued to leak from the Fukushima nuclear plant damaged by the March 11 earthquake and tsunami, Agence France-Presse reports.

25 Mar 2011

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

NewYork-Presbyterian Hospital has established a Pediatric Physical Medicine and Rehabilitation Service, led by Dr. Heakyung Kim. In this role, Dr. Kim will provide specialized care for children with neuromuscular disorders and other special needs at the Hospital's two major centers for pediatric care: Morgan Stanley Children's Hospital at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Komansky Center for Children's Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

25 Mar 2011

Covaris launches Bench-top SF220 Formulation Processing System

Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.

25 Mar 2011

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Chronic Obstructive Pulmonary Disease (COPD) is a major cause for hospital stays and emergency room visits across Canada and researchers say minimizing exacerbations or flare-ups of the disease can go a long way to reducing hospitalizations.

25 Mar 2011

Polls showcase national divisions, opinions about health law

A year has passed and polls still highlight the steadiness in the public rift on the health law.

25 Mar 2011

AssureRx closes $11 million Series B financing

AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.

25 Mar 2011

Merck to return rights for betrixaban to Portola

Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.

25 Mar 2011

IOM offers standards to develop clinical practice guidelines

Modern Healthcare reports that the Institute of Medicine has issued eight recommended standards to develop clinical practice guidelines. Meanwhile, it also reports on the findings of a national survey regarding medical mistakes.

25 Mar 2011

Qualifacts CareLogic Enterprise achieves Complete EHR certification

Qualifacts Systems Inc. announced at the kickoff of its 2011 Users' Conference that CareLogic Enterprise is 2011/2012 compliant and was certified as a Complete EHR on March 22, 2011, by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services.

25 Mar 2011

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

Biostar fourth quarter revenues increase 65.7% to $28.2 million

Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the fourth quarter and full year ended December 31, 2010.

25 Mar 2011

First Edition: March 25, 2011

In his latest Kaiser Health News column, John Goodman writes: "As governors across the land struggle with fiscal pressures and pepper the federal government with requests to scale back Medicaid - many people are losing sight of the fact that health care reform requires a huge expansion of Medicaid".

25 Mar 2011

'Consent rituals' cause life-threatening delays

Current rules requiring researchers to obtain consent for patients to take part in clinical trials in emergency situations are causing life-threatening delays to treatment, experts have argued.

25 Mar 2011

Graceway receives FDA approval for Zyclara Cream to treat genital warts

Graceway Pharmaceuticals announced today that the Food and Drug Administration has approved Zyclara Cream for the treatment of external genital and perianal warts in patients 12 years of age and older.

25 Mar 2011